Senior People Partner, Docplanner

What is most compelling about Docplanner’s business journey has been its long-brewing competition with their direct competitor, the fellow Unicorn and better-funded Doctolib. The tête-à-tête with this French/German rival has seen both parties making aggressive European expansion with national acquisitions - Doctolib in Italy, France, and Germany; Docplanner in Turkey, Poland, Spain, and Latin America. With Docplanner’s 2021 acquisition of German parallel platform Jameda, however, they are making moves on Doctolib’s home turf. The company has also acquired MyDr, a leading Polish tech solutions provider.

These broad consolidation moves represent a maturation of the healthtech market which will serve both competitors well. Docplanner is certainly a key and aggressive contender in this race - and this company isn't going anywhere any time soon.